SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-016999
Filing Date
2020-06-18
Accepted
2020-06-18 08:30:33
Documents
2
Period of Report
2020-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5983
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4445
  Complete submission text file 0000899243-20-016999.txt   12056
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Issuer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VENROCK ASSOCIATES 7 BRYANT PARK, 23RD FLOOR NEW YORK NY 10018
Business Address
EVNIN ANTHONY B (Reporting) CIK: 0001239241 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31141 | Film No.: 20971290